Skip Nav Destination
Refractory Hodgkin lymphoma: time for targeted therapies?
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
Transformation of chronic lymphocytic leukemia into B-cell acute lymphoblastic leukemia
Issue Archive
March 15 2018
Table of Contents
BLOOD COMMENTARIES
CLINICAL TRIALS AND OBSERVATIONS
Refractory Hodgkin lymphoma: time for targeted therapies?
Clinical Trials & Observations
PLENARY PAPER
THROMBOSIS AND HEMOSTASIS
PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke
Ranjeet K. Sinha,Yaoming Wang,Zhen Zhao,Xiao Xu,Laurent Burnier,Naveen Gupta,José A. Fernández,Greg Martin,Sergey Kupriyanov,Laurent O. Mosnier,Berislav V. Zlokovic,John H. Griffin
PERSPECTIVE
CLINICAL TRIALS AND OBSERVATIONS
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
Clinical Trials & Observations
Alex F. Herrera,Alison J. Moskowitz,Nancy L. Bartlett,Julie M. Vose,Radhakrishnan Ramchandren,Tatyana A. Feldman,Ann S. LaCasce,Stephen M. Ansell,Craig H. Moskowitz,Keenan Fenton,Carol Anne Ogden,David Taft,Qu Zhang,Kazunobu Kato,Mary Campbell,Ranjana H. Advani
HEMATOPOIESIS AND STEM CELLS
The impact of aging on primate hematopoiesis as interrogated by clonal tracking
Kyung-Rok Yu,Diego A. Espinoza,Chuanfeng Wu,Lauren Truitt,Tae-Hoon Shin,Shirley Chen,Xing Fan,Idalia M. Yabe,Sandhya Panch,So Gun Hong,Samson Koelle,Rong Lu,Aylin Bonifacino,Allen Krouse,Mark Metzger,Robert E. Donahue,Cynthia E. Dunbar
LYMPHOID NEOPLASIA
Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia
Pavlina Janovska,Jan Verner,Jiri Kohoutek,Lenka Bryjova,Michaela Gregorova,Marta Dzimkova,Hana Skabrahova,Tomasz Radaszkiewicz,Petra Ovesna,Olga Vondalova Blanarova,Tereza Nemcova,Zuzana Hoferova,Katerina Vasickova,Lucie Smyckova,Alexander Egle,Sarka Pavlova,Lucie Poppova,Karla Plevova,Sarka Pospisilova,Vitezslav Bryja
PLATELETS AND THROMBOPOIESIS
RED CELLS, IRON, AND ERYTHROPOIESIS
Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance
Souvik Bhattacharjee,Isabelle Coppens,Alassane Mbengue,Niraja Suresh,Mehdi Ghorbal,Zdenek Slouka,Innocent Safeukui,Hsin-Yao Tang,David W. Speicher,Robert V. Stahelin,Narla Mohandas,Kasturi Haldar
TRANSPLANTATION
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion
Betül Oran,Rima M. Saliba,Yudith Carmazzi,Marcos de Lima,Gabriela Rondon,Sairah Ahmed,Amin Alousi,Borje S. Andersson,Paolo Anderlini,Michelle Alvarez,Qasier Bashir,Stefan Ciurea,Marcelo Fernandez-Vina,Chitra Hosing,Partow Kebriaei,Martin Korbling,Pedro Cano,Issa Khouri,David Marin,Yago Nieto,Amanda Olson,Uday Popat,Katy Rezvani,Muzaffar Qazilbash,Elizabeth J. Shpall,Richard E. Champlin,Kai Cao
LETTER TO BLOOD
Transformation of chronic lymphocytic leukemia into B-cell acute lymphoblastic leukemia
Clinical Trials & Observations
BLOOD WORK
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS
-
Cover Image
Cover Image
Megakaryocyte colonies grown in vitro in cocultures with bone marrow endothelial progenitor cells (BM EPCs) from corticosteroid-sensitive immune thrombocytopenia (ITP) patients. Colonies were defined as groups of 3 or more GPIIb/IIIa-positive cells by immunocytochemical staining. Atorvastatin treatment improves colony-forming unit–plating efficiency and promotes megakaryocytopoiesis in cultures with BM EPCs from corticosteroid-resistant ITP patients. See the article by Kong et al on page 1219.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals